LineaRx, Inc. (an Applied DNA Sciences, Inc. (NASDAQ: APDN) company) delivers enzymatically produced LinearDNA™ as an alternative to current plasmid-based DNA manufacturing processes with advantages of speed, purity, and scalability to support the next generation of nucleic acid-based therapies. Manufactured by a proprietary, large-scale polymerase chain reaction (‘PCR’)-based manufacturing platform, LinearDNA allows for the rapid and efficient cell-free production of high-fidelity DNA sequences. LinearDNA is relevant to a broad array of advanced therapeutics, including mRNA production, DNA vaccines, cell and gene therapies, as well as numerous veterinary medicine applications. Formed in 2018 to commercialize our parent company’s 20+ years of experience and leadership in enzymatic DNA production, LinearRx stands ready to deliver a new generation of DNA for the next generation of medicines. LineaRx, We are DNA Made Simple.
View Top Employees from LineaRx, Inc.| Website | https://www.linearxdna.com/ |
| Revenue | $3 million |
| Employees | View employees |
| Address | 50 Health Sciences Dr, Stony Brook, New York 11790, US |
| Phone | (631) 240-8801 |
| Technologies |
JavaScript,
HTML,
PHP
+10 more
(view full list)
|
| Industry | Biotechnology Research, Pharmaceuticals, Healthcare |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325414 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular LineaRx, Inc. employee's phone or email?
LineaRx, Inc. Questions
The LineaRx, Inc. annual revenue was $3 million in 2024.
LineaRx, Inc. is based in Stony Brook, New York.
The NAICS codes for LineaRx, Inc. are [32541, 325414, 3254, 325, 32].
The SIC codes for LineaRx, Inc. are [28, 283].
Related Companies
